0001179110-21-000428.txt : 20210108
0001179110-21-000428.hdr.sgml : 20210108
20210108083540
ACCESSION NUMBER: 0001179110-21-000428
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210107
FILED AS OF DATE: 20210108
DATE AS OF CHANGE: 20210108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lutz Robert Matthew
CENTRAL INDEX KEY: 0001786203
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37569
FILM NUMBER: 21515765
MAIL ADDRESS:
STREET 1: 900 NORTHBROOK DRIVE
STREET 2: SUITE 200
CITY: TREVOSE
STATE: PA
ZIP: 19053
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Strongbridge Biopharma plc
CENTRAL INDEX KEY: 0001634432
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981130690
STATE OF INCORPORATION: L2
BUSINESS ADDRESS:
STREET 1: 900 NORTHBROOK DRIVE, SUITE 200
CITY: TREVOSE
STATE: PA
ZIP: 19053
BUSINESS PHONE: (610) 254-9200
MAIL ADDRESS:
STREET 1: 900 NORTHBROOK DRIVE, SUITE 200
CITY: TREVOSE
STATE: PA
ZIP: 19053
FORMER COMPANY:
FORMER CONFORMED NAME: Cortendo AB
DATE OF NAME CHANGE: 20150219
4
1
edgar.xml
FORM 4 -
X0306
4
2021-01-07
0
0001634432
Strongbridge Biopharma plc
SBBP
0001786203
Lutz Robert Matthew
900 NORTHBROOK DRIVE
SUITE 200
TREVOSE
PA
19053
0
1
0
0
Chief Financial Officer
Ordinary Shares
2021-01-07
4
A
0
147500
0
A
188311
D
Represents a grant of restricted stock units, which vest in full on January 7, 2023, provided the Reporting Person is employed by the Issuer on such date. Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
/s/ Judith Goldberg, as attorney-in-fact
2021-01-08